PBPH vs. GNOM
PBPH (Portfolio Building Block World Pharma and Biotech Index ETF) and GNOM (Global X Genomics & Biotechnology ETF) are both Health & Biotech Equities funds - PBPH tracks the BITA Global Pharma and Biotech Select Index while GNOM tracks the Solactive Genomics Index. Both are passively managed. Their 0.51 correlation means they have sometimes moved together and sometimes differently. PBPH charges 0.13%/yr vs 0.50%/yr for GNOM.
Performance
PBPH vs. GNOM - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, PBPH achieves a 8.43% return, which is significantly lower than GNOM's 24.03% return.
PBPH
- 1D
- 1.39%
- 1M
- -0.81%
- 6M
- 2.48%
- YTD
- 8.43%
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
- ALL TIME*
- —
GNOM
- 1D
- 0.91%
- 1M
- -4.26%
- 6M
- 20.49%
- YTD
- 24.03%
- 1Y
- 63.15%
- 3Y*
- 6.98%
- 5Y*
- -9.91%
- 10Y*
- —
- ALL TIME*
- -0.91%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $838.94K | $1.34M | $1.39M | |
| $2.59M | $2.37M | $3.76M |
PBPH vs. GNOM - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
PBPH Portfolio Building Block World Pharma and Biotech Index ETF | 8.43% | 0.74% |
GNOM Global X Genomics & Biotechnology ETF | 24.03% | 2.46% |
Correlation
The correlation between PBPH and GNOM is 0.51, which is moderate. They have sometimes moved together and sometimes differently, sharing some price drivers without tracking each other closely.
| Correlation | |
|---|---|
Correlation (All Time) Calculated using the full available price history since Nov 25, 2025 | 0.51 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
PBPH vs. GNOM — Risk / Return Rank
PBPH
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
GNOM
PBPH vs. GNOM - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Portfolio Building Block World Pharma and Biotech Index ETF (PBPH) and Global X Genomics & Biotechnology ETF (GNOM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| PBPH | GNOM | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | — | 1.36 | — |
| Calmar ratioReturn relative to maximum drawdown | — | 3.49 | — |
| Martin ratioReturn relative to average drawdown | — | 9.73 | — |
Loading charts...
Drawdowns
PBPH vs. GNOM - Drawdown Comparison
The maximum PBPH drawdown since its inception was -11.10%, smaller than the maximum GNOM drawdown of -75.00%. Use the drawdown chart below to compare losses from any high point for PBPH and GNOM.
Loading charts...
Drawdown Indicators
| PBPH | GNOM | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -11.10% | -75.00% | +63.90% |
Max Drawdown (1Y)Largest decline over 1 year | — | -18.17% | — |
Max Drawdown (3Y)Largest decline over 3 years | — | -43.29% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -72.14% | — |
Current DrawdownCurrent decline from peak | -2.39% | -48.75% | +46.36% |
Average DrawdownAverage peak-to-trough decline | -4.03% | -40.77% | +36.74% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | — | 6.51% | — |
Volatility
PBPH vs. GNOM - Volatility Comparison
Loading charts...
Volatility by Period
| PBPH | GNOM | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | — | 7.85% | — |
Volatility (6M)Calculated over the trailing 6-month period | — | 20.90% | — |
Volatility (1Y)Calculated over the trailing 1-year period | 17.84% | 27.37% | -9.53% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 17.84% | 33.66% | -15.82% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 17.84% | 34.06% | -16.22% |
PBPH vs. GNOM - Expense Ratio Comparison
PBPH has a 0.13% expense ratio, which is lower than GNOM's 0.50% expense ratio.
Dividends
PBPH vs. GNOM - Dividend Comparison
PBPH's dividend yield for the trailing twelve months is around 0.08%, less than GNOM's 1.15% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
GNOM Global X Genomics & Biotechnology ETF | 1.15% | 1.37% | 0.00% | 0.00% | 0.00% | 0.03% | 0.14% |
PBPH Portfolio Building Block World Pharma and Biotech Index ETF | 0.08% | 0.09% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
PBPH and GNOM have a correlation of 0.51, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, PBPH is cheaper at 0.13% per year. The better choice depends on whether you care most about return, fees, risk, or income.
PBPH is cheaper with a 0.13% expense ratio, compared with 0.50% for GNOM.
GNOM has the higher dividend yield at 1.15%, compared with 0.08% for PBPH.
PBPH tracks BITA Global Pharma and Biotech Select Index, while GNOM tracks Solactive Genomics Index. They also come from different issuers: Portfolio Building Block and Global X. Their fees differ too: 0.13% for PBPH and 0.50% for GNOM.
Find the right allocation for PBPH and GNOM
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer